Vertex Pharmaceuticals has made its largest merger and acquisition deal to date as part of its growth strategy. The move comes as the pharmaceutical industry is seeing a trend of large deals, with some outlets suggesting that companies may need to pursue bolder M&A strategies to stay competitive. The impact of the deal on Vertex Pharmaceuticals is uncertain, with some reports indicating that the company has faced challenges with rising costs.